Millions of individuals rely on effective medications to manage diseases like cancer and diabetes. For those with chronic ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

A 6.5-month-old boy with the rare inherited urea cycle disorder ornithine transcarbamylase (OTC) deficiency has responded positively in a targeted in vivo gene editing trial, in which a correct copy ...

Olverembatinib demonstrated activity in patients with CP-CML who received first- or second-generation TKIs as first-line therapy.

In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with ...

A rare type of blood cancer called chronic myelogenous leukaemia could benefit from new research that can help identify which medicine will work best.

Accumulation of leukemic lymphocytes: Abnormal lymphocytes infiltrate the bone marrow, bloodstream, lymphatic tissues, and organs such as the spleen and liver. This infiltration disrupts normal ...

About 9,560 new cases will be diagnosed with CML (5,610 in men and 3,950 in women) About 1,290 people will die of CML (740 men and 550 women) About 15% of all new cases of leukemia are chronic myeloid ...

An estimated one-third of patients who require SPRYCEL ® treatment may also take gastric acid-reducing agents 1 ... PHYRAGO™ is indicated for adult patients with newly diagnosed Philadelphia ...

Information on treatment success rates for AML in adults can be found in Treatment Response Rates for Acute Myeloid Leukemia. Our team is made up of doctors and oncology certified nurses with deep ...